Biosensors & POCT– category –
-
GraphWear Technologies Revolutionizes Diabetes Management with Needle-Free Sweat-Based CGM Wearable
MTEC USA Overview GraphWear Technologies is developing investigational needle-free continuous glucose monitoring (CGM) wearables using nanotechnology-based skin sensors. This wearable patch sensor is designed to continuously measure gluc... -
Shanghai Jiao Tong University Achieves High-Fidelity EMG Robot Control and Character Recognition with Nepenthes-Inspired Stretchable Electronic Skin
EurekAlert! (Shanghai Jiao Tong University Journal Center) China Overview Researchers at Shanghai Jiao Tong University have developed a Nepenthes-inspired Janus e-skin (SPTL), achieving active sweat management, high breathability, and wa... -
Romanian Innovator PRION POCT Accelerates Critical Biomarker Detection with 15-Minute Point-of-Care Devices
MTEC Romania Overview PRION POCT, a Romanian company, is advancing medical diagnostics with point-of-care (POCT) devices that provide rapid, quantitative detection of cardiac and other critical biomarkers from whole-blood samples in just... -
University of Illinois Develops VPodDuo: A Handheld Molecular Diagnostic Device Detecting Pathogens from Zika to Cancer Markers
University of Illinois USA Overview Researchers at the University of Illinois have developed VPodDuo, a handheld molecular diagnostic device enabling point-of-care (POC) testing outside centralized laboratories. This device can accuratel... -
diaTribe.org Recommends 6 Wearable Devices for Diabetes Management, Featuring Apple Watch & Samsung Galaxy Watch Integration
diaTribe.org USA Overview diaTribe.org has highlighted six wearable devices, including Apple Watch, Samsung Galaxy Watch, Google Pixel Watch, and Garmin Watch, that enhance diabetes management. These devices integrate with CGM systems li... -
Iowa State University Develops Graphene Biosensor for Real-time Sub-ppb Pesticide Detection
HALO Science (Iowa State University) USA Overview Researchers at Iowa State University have developed a low-cost, field-deployable graphene-based microfluidic biosensor platform for rapid quantification of pesticide drift and runoff in a... -
Roche Maximizes Clinical Value by Accelerating Emergency and Infectious Disease Diagnostics with POCT Technology
Roche Switzerland Overview Roche emphasizes that Point-of-Care Testing (POCT) maximizes its value in urgent care and infectious disease diagnostics, such as sepsis and COVID-19, by enabling rapid clinical decision-making. Advances in bio... -
Dexcom’s Stelo Achieves OTC Approval, Leading CGM Market for Non-Insulin Type 2 Diabetes Patients
CNET USA Overview Dexcom's Stelo has received FDA over-the-counter (OTC) approval, establishing it as a market leader in continuous glucose monitoring (CGM) for non-insulin users with Type 2 diabetes. The device provides real-time glucos... -
Biosensors & POCT Weekly Report July 19, 2026
📄 Weekly Report July 19, 2026 (PDF) — Download Weekly Report July 19, 2026 (PDF) — DownloadDownload 🎙 Podcast July 19, 2026 (MP3) — Play & Download BiosensorsEnglishPodcast_20260719.mp3Download View Past Weekly Reports→ -
AI and At-Home Testing Revolutionize POCT Diagnostics, Cambridge Healthtech Institute Reports Trends
Cambridge Healthtech Institute USA Overview A conference by the Cambridge Healthtech Institute focused on the rapid transformation of Point-of-Care Testing (POCT) driven by AI and the expansion of at-home testing. The discussions explore...
